http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007264333-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ba0e9a73754a1714919d3f2ca78c392b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_026128167f73434dfca19ab461a62464
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2c8b79849b4b4174de620147df333156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_350203c5d3f3944fc56a3f0adcee2828
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-402
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-402
filingDate 2007-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2493a8e547978477866a64160939d30f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b9f03d707c7c4c5acf41fd2feb6c53b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03908f8b86494c8deb42356c7b9af61a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c72f90f3695d3558f82cbb134a4dffa1
publicationDate 2007-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2007264333-A1
titleOfInvention Method of treatment
abstract The invention provides the use of darifenacin, or a pharmaceutically acceptable derivative thereof, in the manufacture of a medicament for the reduction of urgency in patients suffering from overactive bladder.
priorityDate 2001-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5096890-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6106864-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5096890-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135767664
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226485998
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID142807983
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536437
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72054
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226439188
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444031
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128126220

Total number of triples: 41.